The trend toward microdosing is gaining momentum as more people realize that aggressive dosing schedules are often counterproductive
However, they also report common side effects
She notes that weight loss is not always visible only in the areas preferred by patients but can affect other parts of the body
Youre ecstaticyouve met your digits and you think, Well, I dont need to take this medication anymore. But what happens if you stop taking it
"Meta-analysis of randomised controlled trials with N-acetylcysteine in schizophrenia." Aust N Z J Psychiatry
For weight management specifically, semaglutide (Wegovy, also approved for adolescents 12 years), liraglutide 3 mg (Saxenda), and tirzepatide (Zepbound) have received FDA approval